Home > Insider Trading > Filing (0001209191-18-021678)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
921114	Ampliphi Biosciences Corp	APHB	Biological Products, (No Disgnostic Substances) (2836)	911549568

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1216486	Curnock Jeremy Cook	C/O Ampliphi Biosciences Corporation 3579 Valley Centre Drive, Suite 100 San Diego CA 92130		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-06-21	15,057	$0.00	71,847	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2016-11-22	46,666	$7.40	118,513	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2017-06-29	5,757	$0.00	124,270	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2017-09-19	105,015	$0.00	229,285	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2018-03-22	181,820	$1.10	411,105	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2016-11-22	46,666	$0.10	46,666	$0.57

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
46,666		2021-11-22	No	4	P	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	330	Direct

Footnotes

The Shares were issued pursuant to a Common Stock Issuance Agreement, dated April 8, 2016, between the Issuer and certain holders of the Issuer's Series B Preferred Stock (the "Holders"), as amended. As consideration for the Shares, among other things, the Holders waived their right to receive certain cash payments to which they were entitled upon the conversion of their Series B Preferred Stock and also waived certain registration rights relating to certain future registration statements or public offerings that may be filed or conducted by the Issuer.
The shares are held by One Funds Management Limited as Trustee for Asia Pacific Healthcare Fund II ("One Funds Management"). The Reporting Person may be deemed to have shared voting and dispositive power over the shares beneficially owned by One Funds Management but disclaims such beneficial ownership, except to the extent of his pecuniary interest therein, if any.
Price reported is reflective of adjustments made to the exercise price after the date of issuance pursuant to the terms of the warrant.
Immediately exercisable.
The warrant is held by One Funds Management. The Reporting Person may be deemed to have shared voting and dispositive power over the securities beneficially owned by One Funds Management but disclaims such beneficial ownership, except to the extent of his pecuniary interest therein, if any.